Medium [CVE-2026-40047] CLI argument injection and path traversal
This medium-severity Red Hat Linux advisory covers CVE-2026-40047 affecting Red Hat build of Apache Camel 4 for Quarkus 3, Red Hat build of Apache Camel for Spring Boot 4.
Aggregated and source-linked by VulniPulse. Data sources, validation and limitations.
VulniPulse record published Record updated
Summary
Improper Neutralization of Argument Delimiters in a Command ('Argument Injection') vulnerability in Apache Camel Docling component. The camel-docling component invokes the external `docling` command-line tool by assembling an argument list in DoclingProducer and executing it through java.lang.
ProcessBuilder. Custom CLI arguments supplied through the `CamelDoclingCustomArguments` exchange header (a List) were appended to that argument list with insufficient validation: the original implementation relied on a denylist of disallowed flags and only rejected path values that contained a literal `../` sequence.
As a result, a Camel route that forwards externally-influenced data into the `CamelDoclingCustomArguments` header (or into the path-bearing headers used to build the invocation) could cause the producer to pass unrecognized or unintended `docling` CLI flags to the subprocess, and could supply path-like argument values that resolved outside the intended directory through traversal sequences not caught by the literal `../` check.
Because Camel itself builds the `docling` invocation from these values, the component is responsible for constraining them, and the weak validation allowed CLI-argument injection and directory traversal in the arguments passed to the external tool. This issue affects Apache Camel: from 4.15.0 before 4.18.3.
Is CVE-2026-40047 exploited?
No exploitation is reported in the sources VulniPulse tracks: CVE-2026-40047 is not in the CISA KEV catalog (checked ) and this advisory does not report exploitation. That is not proof the vulnerability cannot be exploited.
How do I fix CVE-2026-40047?
Upgrade to a fixed release named by Red Hat:
- 4.18
- 4.18.3
Confirm against the vendor advisory before you patch.
- < 4.15.0
- < 4.18.3
Official advisory · high-confidence parse· fetched 11 days ago·verify at source
- 4.18
- 4.18.3
Official advisory · high-confidence parse· fetched 11 days ago·verify at source
Mitigation checklist
- For deployments that cannot upgrade immediately, strip the CamelDoclingCustomArguments header from inbound HTTP messages before the docling producer (for example removeHeaders('CamelDocling*') at the start of the route). Additionally, restrict HTTP endpoint access with authentication.
Official advisory · high-confidence parse· fetched 11 days ago·verify at source
Get an email when Red Hat publishes the next one.
See Red Hat's last 90 days of advisories first. Then choose one product with live alerts free for life, or a free month of real-time alerts on everything with the severity, the fixed version and the vendor's link (card needed, then US$15/month; we email you before the first charge).
More Red Hat Linux advisories
- CVE-2026-119977Oct 31, 2026Arbitrary code execution via predictable upgrade staging paths
- CVE-2026-111497Oct 22, 2026Out-of-Bounds Write in Google Brotli Decoder
- CVE-2026-109619Oct 21, 2026fatal error handling retains stale request state leading to use-after-free
- CVE-2026-109618Oct 21, 2026OOM bailout during request parsing leads to memory corruption and RCE
- CVE-2026-97229Oct 13, 2026integer overflow issue in CI/CD regular expression compiler
- CVE-2026-64849Aug 17, 2026Unauthenticated full-read SSRF in webhook delivery: _validate_webhook_url bypassed
iPhone and Android apps · New on the App Store
Monitor future Red Hat Linux CVEs from your phone.
Choose a whole vendor or a precise platform, then receive matching security advisories by phone notification, email, or both. Coverage follows 34 official vendor sources and 160+ reviewed platform categories.
Discussion(0)
No comments yet. Share field notes, upgrade gotchas, or questions — verify against the vendor advisory before acting on community advice.
Sign in to join the discussion.